Dr. Jeffrey Horowitz, PhD

Claim this profile
Studies Obesity
Studies Insulin Resistance
1 reported clinical trial
2 drugs studied

Clinical Trials Jeffrey Horowitz, PhD is currently running

Image of trial facility.

Exercise

for Weight Loss

Study Purpose: The combination of caloric restriction and exercise is the most common first-line treatment for obesity-related disorders, yet we know very little about how these two very different treatments work together. A deeper understanding about mechanisms underlying the health benefits of adding exercise to a weight loss program will not only aid efforts to optimize more effective lifestyle interventions, but it can also uncover novel targets for the treatment/prevention of obesity-related diseases. Although a reduction in body fat is the fundamental adaptation to weight loss, we know almost nothing about the effects that adding exercise has on structural and functional changes within fat tissue that may further enhance metabolic health. This is very important because many obesity-related metabolic health complications are tightly linked with abnormalities in abdominal fat tissue. We argue exercise-induced modifications in abdominal fat tissue will reveal persistent health benefits even if some weight is regained Study Summary: 10% Weight Loss Phase - Subject participation in the study will involve a series of metabolic tests before, at midpoint, and after undergoing a 10% weight loss program (with or without exercise training depending on group randomization). During this, subjects will be randomized into one of two different experimental groups: 1. Moderate Intensity Continuous Training (MICT) exercise group 2. No exercise (control) group Follow-up Phase: After completing the metabolic testing post-weight loss, all study-related diet and exercise supervision will end and subjects will be free to make their own choices regarding diet and exercise/physical activity behavior. Subjects will then be asked to complete follow-up testing at 2-, 4- and 6- months post-weight loss. Total involvement in the study for each subject will likely be about 10-13 months (4-7 months during weight loss phase, 6 months during follow-up phase).
Recruiting1 award N/A5 criteria

More about Jeffrey Horowitz, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Jeffrey Horowitz, PhD has experience with
  • MICT Exercise
  • No Exercise (Control)
Breakdown of trials Jeffrey Horowitz, PhD has run
Insulin Resistance
Metabolic Syndrome
Metabolic Disorders

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey Horowitz, PhD specialize in?
Jeffrey Horowitz, PhD focuses on Obesity and Insulin Resistance. In particular, much of their work with Obesity has involved treating patients, or patients who are undergoing treatment.
Is Jeffrey Horowitz, PhD currently recruiting for clinical trials?
Yes, Jeffrey Horowitz, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey Horowitz, PhD has studied deeply?
Yes, Jeffrey Horowitz, PhD has studied treatments such as MICT Exercise, No Exercise (Control).
What is the best way to schedule an appointment with Jeffrey Horowitz, PhD?
Apply for one of the trials that Jeffrey Horowitz, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.